---
title: "CERS.US (CERS.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CERS.US/news.md"
symbol: "CERS.US"
name: "CERS.US"
parent: "https://longbridge.com/en/quote/CERS.US.md"
datetime: "2026-05-20T19:39:29.107Z"
locales:
  - [en](https://longbridge.com/en/quote/CERS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CERS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CERS.US/news.md)
---

# CERS.US (CERS.US) — Related News

### [Top 3 Health Care Stocks That May Collapse This Month](https://longbridge.com/en/news/285076294.md)
*2026-05-04T12:44:43.000Z*
> Three healthcare stocks, Avanos Medical (AVNS), Apellis Pharmaceuticals (APLS), and Cerus Corp (CERS), are showing signs

### [Cerus Corporation Earnings Call Signals Profitable Growth](https://longbridge.com/en/news/284948765.md)
*2026-05-02T00:22:33.000Z*
> Cerus Corporation's Q1 earnings call highlighted strong revenue growth, with product revenue up 24% year-over-year to $5

### [Top 10 US Stock Gainers (5.1)](https://longbridge.com/en/news/284944511.md)
*2026-05-01T22:00:41.000Z*
> Esperion Therap(ESPR) rose 55.5%, with a trading turnover 569.3 Million USD, and a year-to-date fell 15.9%. Cerus(CERS) 

### [Cerus (NASDAQ:CERS) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS](https://longbridge.com/en/news/284858131.md)
*2026-05-01T01:54:08.000Z*
> Cerus (NASDAQ:CERS) reported quarterly earnings of ($0.01) EPS, exceeding estimates by $0.02. Revenue reached $59.89 mil

### [Cerus Q1 2026 Earnings Call Transcript](https://longbridge.com/en/news/284841198.md)
*2026-04-30T21:31:41.000Z*
> Cerus Corporation (NASDAQ:CERS) reported a 24% increase in Q1 2026 product revenue to $53.7 million, driven by strong pe

### [Cerus Corp 1Q 2026: Revenue $59.9M, EPS $(0.01) — 10-Q Summary](https://longbridge.com/en/news/284837799.md)
*2026-04-30T21:11:01.000Z*
> Cerus Corp reported Q1 2026 results with revenue of $59.9M, a 23% increase year-over-year, and a narrowed net loss of $1

### [Cerus | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 59.89 M](https://longbridge.com/en/news/284836805.md)
*2026-04-30T21:07:39.000Z*
### [](https://longbridge.com/en/news/284831492.md)
*2026-04-30T20:25:39.000Z*
> Cerus shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY26